And that ends starting today. The other countries are not happy with us. I don't think they like me too much, Bobby, but that's okay. Eli Lilly and Novo Nordisk are committing to offer [Zepbound and Wegovy] at most favored nations rates for American patients. This will slash the cost of WeGovy from $1,350 a month to ultimately $250 a month. $1,350 to $250. Did I do a good job? They don't write about it. (25:42–25:52)
CLAIM
Asserts that Eli Lilly and Novo Nordisk will offer these drugs at reduced rates for Americans.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
